Literature DB >> 32332048

How COVID-19 Has Changed the Management of Glomerular Diseases.

Andrew S Bomback1, Pietro A Canetta2, Wooin Ahn2, Syeda B Ahmad2, Jai Radhakrishnan2, Gerald B Appel2.   

Abstract

Entities:  

Keywords:  COVID-19; glomerular disease; immunosuppression; kidney diseases; severe acute respiratory syndrome coronavirus 2

Mesh：

Substances：

Year:  2020        PMID： 32332048      PMCID： PMC7274282          DOI： 10.2215/CJN.04530420

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  8 in total

1.  Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Authors:  Fernando C Fervenza; Gerald B Appel; Sean J Barbour; Brad H Rovin; Richard A Lafayette; Nabeel Aslam; Jonathan A Jefferson; Patrick E Gipson; Dana V Rizk; John R Sedor; James F Simon; Ellen T McCarthy; Paul Brenchley; Sanjeev Sethi; Carmen Avila-Casado; Heather Beanlands; John C Lieske; David Philibert; Tingting Li; Lesley F Thomas; Dolly F Green; Luis A Juncos; Lada Beara-Lasic; Samuel S Blumenthal; Amy N Sussman; Stephen B Erickson; Michelle Hladunewich; Pietro A Canetta; Lee A Hebert; Nelson Leung; Jay Radhakrishnan; Heather N Reich; Samir V Parikh; Debbie S Gipson; Dominic K Lee; Bruno R da Costa; Peter Jüni; Daniel C Cattran
Journal:  N Engl J Med       Date:  2019-07-04       Impact factor: 91.245

2.  Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.

Authors:  Matthew A Sparks; Andrew South; Paul Welling; J Matt Luther; Jordana Cohen; James Brian Byrd; Louise M Burrell; Daniel Batlle; Laurie Tomlinson; Vivek Bhalla; Michelle N Rheault; María José Soler; Sundar Swaminathan; Swapnil Hiremath
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-27       Impact factor: 8.237

3.  Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York.

Authors: 
Journal:  J Am Soc Nephrol       Date:  2020-04-21       Impact factor: 10.121

4.  Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.

Authors:  Michael Walsh; Peter A Merkel; Chen-Au Peh; Wladimir M Szpirt; Xavier Puéchal; Shouichi Fujimoto; Carmel M Hawley; Nader Khalidi; Oliver Floßmann; Ron Wald; Louis P Girard; Adeera Levin; Gina Gregorini; Lorraine Harper; William F Clark; Christian Pagnoux; Ulrich Specks; Lucy Smyth; Vladimir Tesar; Toshiko Ito-Ihara; Janak Rashme de Zoysa; Wojciech Szczeklik; Luis Felipe Flores-Suárez; Simon Carette; Loïc Guillevin; Charles D Pusey; Alina L Casian; Biljana Brezina; Andrea Mazzetti; Carol A McAlear; Elizabeth Broadhurst; Donna Reidlinger; Samir Mehta; Natalie Ives; David R W Jayne
Journal:  N Engl J Med       Date:  2020-02-13       Impact factor: 91.245

5.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

6.  Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Authors:  Jicheng Lv; Hong Zhang; Muh Geot Wong; Meg J Jardine; Michelle Hladunewich; Vivek Jha; Helen Monaghan; Minghui Zhao; Sean Barbour; Heather Reich; Daniel Cattran; Richard Glassock; Adeera Levin; David Wheeler; Mark Woodward; Laurent Billot; Tak Mao Chan; Zhi-Hong Liu; David W Johnson; Alan Cass; John Feehally; Jürgen Floege; Giuseppe Remuzzi; Yangfeng Wu; Rajiv Agarwal; Hai-Yan Wang; Vlado Perkovic
Journal:  JAMA       Date:  2017-08-01       Impact factor: 56.272

7.  Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.

Authors:  Shane A Bobart; An S De Vriese; Aditya S Pawar; Ladan Zand; Sanjeev Sethi; Callen Giesen; John C Lieske; Fernando C Fervenza
Journal:  Kidney Int       Date:  2019-02       Impact factor: 10.612

8.  Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.

Authors:  A H Jan Danser; Murray Epstein; Daniel Batlle
Journal:  Hypertension       Date:  2020-03-25       Impact factor: 10.190
  8 in total
  10 in total

Review 1.  COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.

Authors:  Xiaojing Chen; Chengyuan Yu; Haijiao Jing; Chunxu Wang; Xinyi Zhao; Jinming Zhang; Shuoqi Zhang; Huan Liu; Rujuan Xie; Jialan Shi
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 2.  Effect of COVID-19 on Kidney Disease Incidence and Management.

Authors:  Meredith McAdams; Mauricio Ostrosky-Frid; Nilum Rajora; Susan Hedayati
Journal:  Kidney360       Date:  2020-11-24

3.  Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team.

Authors:  Cal Robinson; Michelle Ruhl; Amrit Kirpalani; Abdullah Alabbas; Damien Noone; Chia Wei Teoh; Valerie Langlois; Veronique Phan; Mathieu Lemaire; Rahul Chanchlani
Journal:  Can J Kidney Health Dis       Date:  2020-11-13

4.  A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.

Authors:  Smaragdi Marinaki; Stathis Tsiakas; Chrysanthi Skalioti; Panayiota Lourida; Aikaterini Argyraki; Konstantinos Grigorakos; Ioannis Boletis
Journal:  Medicina (Kaunas)       Date:  2020-07-17       Impact factor: 2.430

Review 5.  COVID-19: a novel menace for the practice of nephrology and how to manage it with minor devastation?

Authors:  Sena Ulu; Ozkan Gungor; Ebru Gok Oguz; Nuri Baris Hasbal; Didem Turgut; Mustafa Arici
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

Review 6.  Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19.

Authors:  Michael R Yeaman
Journal:  Glomerular Dis       Date:  2021-08-25

7.  Membranous nephropathy in a patient with COVID-19 infection.

Authors:  Weiwen Guo; Puay Hoon Tan; Shashidhar Baikunje
Journal:  J Nephrol       Date:  2021-10-07       Impact factor: 3.902

8.  Impact of COVID 19 pandemic on patients requiring renal biopsy.

Authors:  Abhilash Chandra; Namrata Rao; Kiran Preet Malhotra; Divya Srivastava
Journal:  Int Urol Nephrol       Date:  2022-03-15       Impact factor: 2.266

Review 9.  COVID-19 and the kidney: what we think we know so far and what we don't.

Authors:  Samira S Farouk; Enrico Fiaccadori; Paolo Cravedi; Kirk N Campbell
Journal:  J Nephrol       Date:  2020-07-20       Impact factor: 3.902

10.  COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic.

Authors:  Vinícius Sardão Colares; Silvana Maria Miranda; Luis Gustavo Modelli de Andrade; Lilian Monteiro Pereira Palma; Maria Cristina Ribeiro de Castro; Cassiano Augusto Braga Silva; Maria Goretti Moreira Guimarães Penido; Roberta Sobral; Maria Helena Vaisbich
Journal:  J Bras Nefrol       Date:  2020-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.